PMA device
Fem Cap
Femcap Incorporated · Cap, Cervical, Contraceptive (LLQ, Class III) · First FDA decision Oct 13, 2011, newest Oct 13, 2011Contraception
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Fem Cap"
MAUDE reports
0
Brand "Fem Cap", since 2015
PubMed studies
3
Mentioning "Fem Cap"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Fem Cap
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Fem Cap", any status and sponsor, newest update first.
No registered device study names "Fem Cap".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Fem Cap", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LLQ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Fem Cap"[tiab]. The summary above synthesizes these.
- Experimental cervical cap has advantages over other methods.
Contracept Technol Update · 1991
- New condoms for men and women, diaphragms, cervical caps, and spermicides: overcoming barriers to barriers and spermicides.
Hatcher RA, Warner DL · Curr Opin Obstet Gynecol · 1992Review
- New female intravaginal barrier contraceptive device. Preliminary clinical trial.
Shihata AA, Trussell J · Contraception · 1991
Other devices of this type
Also filed under product code LLQ.
- Lea's Shield Barrier ContraceptiveYama, Inc. · PMA 2004
- FemcapFemcap Incorporated · PMA 2013
- Femcap Barrier ContraceptiveFemcap Incorporated · PMA 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.